Question 1

What is the catalog number for Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant)?

Accepted Answer

The catalog number for Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant) is 22060766-2.

Question 2

What sizes are available for Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant)?

Accepted Answer

Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant) is available in the following size(s): 10 µg.

Question 3

Is Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant) in stock?

Accepted Answer

Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 5

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Human Granulocyte-Colony Stimulating Factor, CHO (Recombinant)

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Adcy1 3'UTR GFP Stable Cell Line

ZSWIM3 (NM_080752) Human Recombinant Protein

H-p-Chloro-Phe-D-Cys-β- (3-pyridyl) -Ala-D-Trp-Lys-tBu-Gly-Cys-2-Nal-NH₂

Ell3 3'UTR Luciferase Stable Cell Line

IL1B Biosimilar Antibody

IL1B Biosimilar Antibody